离子凝聚法制备负载流感疫苗的壳聚糖微球

采用三聚磷酸钠(TPP)作为离子交联剂, 应用离子凝聚法制备负载流感疫苗的壳聚糖微球. 筛选出壳聚糖起始质量分数为1%. TPP的浓度对壳聚糖微球的制备影响较大, 采用低浓度的TPP(200 μg/mL)制备的微球放置过夜均出现沉淀现象, 高浓度的TPP(800 μg/mL)在制备过程中出现絮状沉淀. 固化比影响微球的释放行为, 固化比为1∶1的微球爆炸式释放率达到90％, 固化比为1∶3的微球6 h后逐步释放, 12 h后释放率达到95％. 固化比为1∶5的微球6 h后没有明显的释放行为. 壳聚糖溶液的pH对微球的制备和释放没有显著的影响. 通过对负载流感疫苗的壳聚糖微球的制备条件和释放行为的研究结果表明, pH=5.6的壳聚糖溶液, 固化比为1∶3, TPP的质量浓度为400 μg/mL是较理想的流感疫苗壳聚糖微球的制备条件.     

壳聚糖修饰PLGA阳离子型纳米微球的制备与表征

采用单乳化-溶剂(O/W)挥发技术制备表面带正电荷的壳聚糖(CHS)修饰聚乙/丙交酯(PLGA)纳米微球(PLGA/CHS), 通过正交试验优化了纳米微球的制备条件. 结果表明, 微球粒径可控制在150～200 nm内, 在pH=4时, 纳米微球表面电位最高为55 mV. 影响微球粒径的主要因素是聚合物的浓度, CHS的分子量和浓度以及介质的pH值对微球表面电位也有明显影响. 制备粒径较小而表面电位较高的PLGA/CHS纳米微球条件为: ρ(CHS)=3 mg/mL, ρ(PLGA)=10 mg/mL, Vo/Va=1/4. SEM图像显示经CHS修饰的PLGA的纳米微球形状规整, 荧光显微观察和XPS分析结果证实CHS包覆于微球表面.     

pH荧光纳米传感器的研制及表征

利用溶胶-凝胶技术制得了单分散性很好的二氧化硅纳米微球,通过共价偶联方式引入对pH变化敏感的荧光素异硫氰酸酯（FITC）,这种FITC功能化二氧化硅纳米微球（FITC功能化硅微球）可作为pH荧光纳米传感器。当pH值从4.0变至7.5时,荧光强度增大约30倍。该传感器灵敏度高,响应速度快,容易制备,光稳定性好,可望用于单细胞的pH分析。     

茶多酚锰-壳聚糖微球的制备、控释和诱导肝癌细胞凋亡的研究

选用壳聚糖为微米粒包被材料, 制备茶多酚锰(Tea Polyphenol Manganese, TPMn)-壳聚糖微球. 用荧光显微技术研究了TPMn-壳聚糖微球的荧光特性, 用扫描和透射电子显微镜证实TPMn-壳聚糖微球尺寸和分布规律. RP-HPLC定量分析TPMn-壳聚糖微球包封率为68%, 符合微米级微粒控释药物包封率的要求. 动力学研究结果表明, 茶多酚(TP)-壳聚糖和TPMn-壳聚糖的微球均有控释TP的能力, 控释时间高达40 h以上, 但前者释放速率稍快于后者. TPMn和TPMn-壳聚糖微球均能诱导肝癌细胞凋亡, 但TPMn-壳聚糖微球诱导肿瘤细胞的凋亡速率稍高于TPM. 实验结果证实, 以TPMn-壳聚糖微球方式控释TPMn有利于提高诱导肿瘤细胞凋亡速率. TPMn-壳聚糖微球具有研发成注射型抗肿瘤新药的可能性.     

壳聚糖水凝胶微球的制备与溶胀性能

采用三聚磷酸钠(TPP)和六偏磷酸钠(SHMP)为复合交联剂,制备了离子交联网络结构的壳聚糖水凝胶微球。分析讨论了交联剂质量配比、pH以及离子强度等对壳聚糖微球溶胀性能的影响。结果表明:使用复合交联剂制备的微球的溶胀度比单独使用TPP或SHMP的分别低62.4%和41.3%,交联效率得到明显提高;当m(TPP)∶m(SHMP)=3∶5,交联剂pH=5时,制备的微球交联程度最好,结构最密实;在pH=1.2的缓冲溶液中,溶胀度可达到357%,而且凝胶没有任何破碎。微球具有较好的离子强度和pH敏感性,在酸性介质中有较高的溶胀度。     

壳聚糖/聚乙烯醇/三聚磷酸钠三元复合微球的制备及其表征

由壳聚糖(CS)、聚乙烯醇(PVA)和三聚磷酸钠(TPP)制备了壳聚糖/聚乙烯醇/三聚磷酸钠三元复合微球,探讨了体系中壳聚糖含量对复合微球的影响,以及离子种类及浓度和pH值对复合微球溶胀度的影响。采用XRD、FTIR和SEM等测试技术对微球的组分、结构和形貌进行了表征。结果表明,CS和PVA具有良好的相容性,随着CS含量的增加,PVA的结晶性逐渐降低,复合微球的粒径约为400～950μm,表面较为粗糙;随着CS添加量的增加,凝胶平衡溶胀度先增大再减小,CS/PVA/TPP复合微球在pH值为3～8的溶胀度最大,且在同一种溶液中,随着离子浓度的增加,其溶胀度明显降低;复合微球具有溶胀-收缩可逆性,显示CS/PVA/TPP复合微球是pH/离子敏感型凝胶,可为药物缓释系统提供实验和理论依据。     

微乳液法制备可共载水溶和脂溶药物的壳聚糖季铵盐乙醇脂质体的载药性能表征

采用微乳液法制备了可包载脂溶性和水溶性药物的羧甲基壳聚糖十八烷基季铵盐(OQCMC)乙醇脂质体,研究了OQCMC乙醇高分子脂质体的相图、粒径和电位、对药物的包封及释放能力及共载水溶性和脂溶性荧光染料后的细胞内递送能力.结果表明:OQCMC上长链季铵盐分子的取代度和共乳化剂乙醇的加入量对相图中微乳区域的面积影响不大;微乳液法可制备包载水溶性长春新碱(VCR)、脂溶性消炎痛(IMC)或二者共载的OQCMC载药微球,微球粒径为(52.40±0.55)nm,分布均匀;微乳液体系对VCR的最大载药率为22.7%,对IMC的最大载药率为20.1%,二者共载时,VCR的最大载药率为12.2%,IMC的最大载药率为10.0%;载药微球对药物具有缓控释功能.OQCMC乙醇高聚物脂质体可有效地包载荧光染料异硫氰酸荧光素FITC(水溶性)和尼罗红(脂溶性),并将二者递送到卵巢癌HO8901细胞内.     

新型有机荧光染料嵌合的核壳荧光纳米材料的研制

采用油包水的反相微乳液方法,首次以羊抗人免疫球蛋白(IgG)标记的异硫氰酸荧光素(FITC)为核材料,成功地制备了FITC的核壳荧光纳米颗粒,克服了采用传统方法制备核壳荧光纳米颗粒中存在的荧光染料泄露的问题.制备的这种核壳荧光纳米颗粒比细胞小很多,且具有生物亲和性,可为纳米生物传感器件提供新型材料.基于该核壳荧光纳米颗粒的标记方法也为生物医学提供了一种新型的非同位素分析方法.     

双发射荧光纳米微球的制备及其用于Hg~(2+)的可视化检测

报道了一种荧光可视化检测Hg~(2+)浓度的新方法。首先通过静电相互作用直接将负电荷的CdTe/CdS量子点自组装在带正电荷异硫氰酸荧光素掺杂的二氧化硅微球(FITC-SiO_2)表面。荧光光谱显示制备的纳米复合微球(FITC-SiO_2-CdTe)同时具有FITC分子绿色及量子点红色的荧光峰。由于Hg~(2+)会与量子点表面的巯基分子结合而猝灭量子点的荧光,而对微球内部的绿色荧光无明显响应,因此可以根据量子点与FITC分子荧光强度比值的改变来检测Hg~(2+)的浓度。标准条件下,量子点与FITC分子荧光强度比值与Hg~(2+)在浓度0~15μmol/L范围内成线性关系,检测限可达0.5μmol/L。另外,随着Hg~(2+)浓度的增加,探针溶液的颜色由红色逐渐变为绿色,这说明可通过肉眼观察溶液荧光颜色的变化估算Hg~(2+)浓度。     

超细荧光聚合物纳米微球的制备

合成了具有较高荧光量子产率(0.69)和良好光稳定性的可聚合荧光染料单体,该荧光染料的光稳定性高于商品化的染料罗丹明B。 通过氧化还原引发剂引发乳液聚合制备了超细荧光聚合物纳米微球,将染料分子共价连接在聚合物链上。 使用非离子表面活性剂Triton X-100作为乳化剂、甲基丙烯酸甲酯(MMA)作为单体和助乳化剂,制备的超细纳米微球平均粒径为22 nm,而不加MMA时制备出的纳米微球平均粒径在150 nm左右。 由于微球表面带有苄氯基团,为进一步的微球功能化提供了途径。     

Immobilization of fluorescein isothiocyanate on magnetic polymeric nanoparticle using chitosan as spacer

The nanoparticle with simultaneous combination of magnetic and fluorescent properties was prepared by immobilization of fluorescein isothiocyanate (FITC) onto magnetic polymeric nanoparticle (MPNP). The MPNP with 41% magnetic content was obtained from incorporating Fe(3)O(4) magnetic nanoparticles (MNPs) into poly(styrene/divinyl benzene/acrylic acid) via the miniemulsion polymerization. Before labeling with FITC, the carboxylated MPNP was coated with chitosan (CS) having low, medium, or high molecular weight (MW) in order to avoid quenching of the fluorescent by iron oxide. Data obtained from TEM, size and zeta potential measurements clearly indicated the presence of CS as a shell surrounding the superparamagnetic MPNP core. The zeta potential, FTIR, and fluorescent spectroscopies confirmed the attachment of FITC to the MPNP-CS via covalent bonding. The higher MW or longer chains of CS (300kDa) offered the larger spacer with multiple sites for the FITC binding and, thus, provided the higher fluorescent emission intensity. The MPNP-CS immobilized with FITC would be useful for cell-labeling application.     

Chitosan nanoparticles crosslinked by glycidoxypropyltrimethoxysilane for pH triggered release of protein

pH-responsive-chitosan nanoparticles for the control release of protein drug were prepared by combining two-step crosslinking method,in which chitosan was subsequently crosslinked by sodium tripolyphosphate(TPP)and glycidoxypropyltrimethoxysilane (GPTMS).Compared with TPP crosslinked chitosan particles,the two-step crosslinked nanoparticles were not only pH-responsive but also more stable in wide pH range.Fluorescein isothiocyanate(FITC)labeled anti-human-IgG antibody was used as a model protein drug for...     

Novel drug delivery system of hollow mesoporous silica nanocapsules with thin shells: preparation and fluorescein isothiocyanate (FITC) release kinetics

Core-shell nanoparticles of Au@silica with a diameter of approximate 45–60 nm and wall thickness in range of 3–10 nm were synthesized by using 40 and 50 nm gold nanoparticles as the templates. The mesoporous particles are regulated by 3-aminopropyltrimethoxysilane addition. Hollow mesoporous silica nanocapsules (HMSNs) were prepared by using sodium cyanide to dissolve the gold cores. The characterization of Au@silica and HMSNs by transmission electronic microscope indicated that the silica shells were uniform and smooth, and also the porosity was proved by fluorescein isothiocyanate (FITC) release experiments. The ratio of hollow core to HMSNs is more than 70%. HMSNs were subsequently used as drug carrier to investigate FITC (as a model drug) release behaviors in vitro. Fluorescent spectrometry was performed to determine the release kinetics from the HMSNs. The release profiles are significantly different as compared with the control (free FITC), which show that HMSNs are good drug carriers to control drug release, and have high potential in therapeutic drugs delivery in future applications.     

Novel nanoparticles composed of chitosan and β-cyclodextrin derivatives as potential insoluble drug carrier

This research was aim to develop novel cyclodextrin/chitosan(CD/CS) nanocarriers for insoluble drug delivery through the mild ionic gelation method previously developed by our lab. A series of different bcyclodextrin(β-CD) derivatives were incorporated into CS nanoparticles including hydroxypropyl-bcyclodextrin(HP-β-CD), sulphobutylether-β-cyclodextrin(SB-β-CD), and 2,6-di-O-methy-β-cyclodextrin(DM-β-CD). Various process parameters for nanoparticle preparation and their effects on physicochemical properties of CD/CS nanoparticles were investigated, such as the type of CD derivatives,CD and CS concentrations, the mass ratio of CS to TPP(CS/TPP), and p H values. In the optimal condition,CD/CS nanoparticles were obtained in the size range of 215–276 nm and with the zeta potential from30.22 m V to 35.79 m V. Moreover, the stability study showed that the incorporation of CD rendered the CD/CS nanocarriers more stable than CS nanoparticles in PBS buffer at p H 6.8. For their easy preparation and adjustable parameters in nanoparticle formation as well as the diversified hydrophobic core of CD derivatives, the novel CD/CS nanoparticles developed herein might represent an interesting and versatile drug delivery platform for a variety of poorly water-soluble drugs with different physicochemical properties.     

Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery

This work investigates the polyanion initiated gelation process in fabricating chitosan-TPP (tripolyphosphate) nanoparticles in the size range of 100-250 nm intended to be used as carriers for the delivery of gene or protein macromolecules. It demonstrates that ionic gelation of cationic chitosan molecules offers a flexible and easily controllable process for systematically and predictably manipulating particle size and surface charge which are important properties in determining gene transfection efficacy if the nanoparticles are used as non-viral vectors for gene delivery, or as delivery carriers for protein molecules. Variations in chitosan molecular weight, chitosan concentration, chitosan to TPP weight ratio and solution pH value were examined systematically for their effects on nanoparticle size, intensity of surface charge, and tendency of particle aggregation so as to enable speedy fabrication of chitosan nanoparticles with predetermined properties. The chitosan-TPP nanoparticles exhibited a high positive surface charge across a wide pH range, and the isoelectric point (IEP) of the nanoparticles was found to be at pH 9.0. Detailed imaging analysis of the particle morphology revealed that the nanoparticles possess typical shapes of polyhedrons (e.g., pentagon and hexagon), indicating a similar crystallisation mechanism during the particle formation and growth process. This study demonstrates that systematic design and modulation of the surface charge and particle size of chitosan-TPP nanoparticles can be readily achieved with the right control of critical processing parameters, especially the chitosan to TPP weight ratio.     

Microstructure formation and property of chitosan-poly(acrylic acid) nanoparticles prepared by macromolecular complex

We report here a study on the microstructure formation process of polymeric nanoparticles based on polyelectrolyte complexes. When polyanion poly(acrylic acid) (PAA) was dropped into polycation chitosan (CS) solution, CS-PAA nanoparticles with diverse microstructure would be formed under different experimental conditions. The microstructure of CS-PAA nanoparticles changed from solid spherical nanoparticles to core-shell separative ones and turned back to solid spherical ones with the variation of preparation conditions. The influence of molecular weight of CS and PAA, shell cross-linking, dropping temperature on the size, stability and morphology of CS-PAA nanoparticles were also studied. The nanoparticle size was affected by the molecular weight of CS and PAA, the ratio of amino group to carboxyl group (na/nc) and the incubation temperature as well. The shell-cross-linking provides a means to stabilize these nanoparticles. These nanoparticles can encapsulate plasmid DNA very well, which makes them have great potential in gene delivery.     

Preparation of chitosan nanoparticles by TPP ionic gelation combined with spray drying,and the antibacterial activity of chitosan nanoparticles and a chitosan nanoparticle–amoxicillin complex

Chitosan nanoparticles were prepared from chitosan with various molecular weights by tripolyphosphate (TPP) ionic gelation combined with a spray drying method. The morphologies and characteristics of chitosan nanoparticles were determined by TEM, FE-SEM and from their mean sizes and zeta potentials. The effect of chitosan molecular weight (130, 276, 760 and 1200 cPs) and size of spray dryer nozzle (4.0, 5.5 and 7.0 µm) on mean size, size distribution and zeta potential values of chitosan nanoparticles was investigated. The results showed that the mean size of chitosan nanoparticles was in the range of 166–1230 nm and the zeta potential value ranged from 34.9 to 59 mV, depending on the molecular weight of chitosan and size of the spray dryer nozzles. The lower the molecular weight of chitosan, the smaller the size of the chitosan nanoparticles and the higher the zeta potential. A test for the antibacterial activity of chitosan nanoparticles (only) and a chitosan nanoparticle–amoxicillin complex against Streptococcus pneumoniae was also conducted. The results indicated that a smaller chitosan nanoparticle and higher zeta potential showed higher antibacterial activity. The chitosan nanoparticle–amoxicillin complex resulted in improved antibacterial activity as compared to amoxicillin and chitosan nanopaticles alone. Using a chitosan nanoparticle–amoxicillin complex could reduce by three times the dosage of amoxicillin while still completely inhibiting S. pneumoniae.     

Detection of Intracellular Proteins and Biomarkers Using Modified Silica Nanoparticles and Flow Cytometry In vitro

In this paper, antibody-modified silica nanoparticles were successfully synthesized, and their average diameter was (109±9) nm. These particles were mixed with cell extracts to target a protein, then, an antibody labeled with fluorescein isothiocyanate(FITC) was added to form FITC-labeled nanoparticle complexes and the product was analyzed using flow cytometry. The results confirm that the intracellular proteins and biomarkers were precisely and sensitivity detected by the novel method in vitro. The FITC intensity of Akt antibody-conjugated particles was increased ≥ 10-fold compared with that of control samples in MCF-7 cells. Furthermore, it can also simultaneously measure several proteins when modified with different antibodies.     

Preparation of chitosan nanoparticles as carrier for immobilized enzyme

This work investigated the preparation of chitosan nanoparticles used as carriers for immobilized enzyme. The morphologic characterization of chitosan nanoparticles was evaluated by scanning electron microscope. The various preparation methods of chitosan nanoparticles were discussed and chosen. The effect of factors such as molecular weight of chitosan, chitosan concentration, TPP concentration, and solution pH on the size of chitosan nanoparticles was studied. Based on these results, response surface methodology was emploved. The results showed that solution pH, TPP concentration, and chitosan concentration significantly affected the size of chitosan nanoparticles. The adequacy of the predictive model equation for predicting the magnitude orders of the size of chitosan nanoparticles was verified effectively by the validation data. Immobilization conditions were investigated as well. The minimum particles size was about 42±5 nm under the optimized conditions. The optimal conditions of immobilization were as follow: one milligram of neutral proteinase was immobilized on chitosan nanoparticles for about 15 min at 40°C. Under the optimized conditions, the enzyme activity yield was 84.3%.     

Influence of cetyltrimethylammonium bromide on physicochemical properties and microstructures of chitosan-TPP nanoparticles in aqueous solutions

The nanoparticles of chitosan (CS) were prepared using pentasodium triphosphate (TPP) as a crosslinking agent and the influences of cetyltrimethylammonium bromide (CTAB) on the physicochemical properties of the CS-TPP nanoparticles were first studied by laser light scattering, zeta potential, and transmission electron microscopy (TEM). The concentration played a significant role in controlling the particle size of CS and the overlap concentration c(*) was testified to be about 1.0 mg/mL. The combination of static light scattering (SLS) and dynamic light scattering (DLS) allowed us to obtain more information about the CS-TPP nanoparticles in the presence of surfactant molecules. The addition of CTAB could reduce the hydrodynamic diameter of nanoparticles effectively in the salt solutions and simultaneously increase the zeta potential of the nanoparticles. The effect of CTAB concentration on the size of CS-TPP nanoparticle was also examined. The critical micelle concentration (CMC) of CTAB was used to interpret the complicated complex formed by the polyelectrolyte and the surfactant. Finally, TEM was used to observe the CS-TPP nanoparticles, which were affected by CTAB, to verify the results obtained by light scattering.